The seventh annual Armada Specialty Pharmacy Summit, convened at The Wynn resort and casino this week, attracted nearly 1,500 attendees — a rise of almost 50% over 2010 — and about 80 exhibiting companies.
Pharmacy benefit manager Medco’s research arm is teaming up with personalized medicine and pharmacogenetics company AssureRx Health in a pilot program to evaluate adherence and medical care utilization among patients taking antidepressants and antipsychotics.
NBTY on Monday identified Marilyn Hatch of Sugar City, Ind., as the grand prize winner of the “Ester-C 24/7 Mom Contest.” Hatch was awarded an eight-day/seven-night cruise for two to the Mediterranean.
Nordic Naturals is attempting to crack the mass channel code with an initial 200-store test with Walgreens, the company told Drug Store News. Nordic boasts a strong heritage across the specialty channel.
Cobalis on Tuesday began airing 60-second television commercials in support of its PreHistin allergy defense formula across national cable and satellite networks as part of a planned $5 million spend, the company announced.
Patients with moderate to severe rheumatoid arthritis who respond to 12 weeks of treatment with a drug made by UCB are more likely to show improvement in their condition in the long run, according to results of a study published in the Journal of Rheumatology.
The Food and Drug Administration will expedite its review of an investigational drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the gastrointestinal tract, the company said Tuesday.
CVS Caremark announced on Tuesday the release of its 2010 corporate social responsibility report, which provides an overview of the company's commitments to environmental stewardship, improving patient health outcomes and positively impacting people's lives through its social investments.
The Centers for Disease Control and Prevention on Monday released the 2012 edition of the agency’s “Yellow Book,” a definitive health guide for international travel that could become the must-have resource for pharmacists looking to recommend travel vaccinations.
The Food and Drug Administration is moving forward in the creation of a regulatory approval pathway for follow-on biologics and is requesting input from stakeholders and the public, the agency said Monday.
Drug maker Merck announced that it has kicked off an initiative that includes a wide range of public education and patient support programs, as well as research efforts to help improve care for people living with chronic hepatitis C virus infections.